Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.140
+0.050 (1.62%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Evolent Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,889 | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 |
Revenue Growth | -21.26% | -26.56% | 30.09% | 45.26% | 48.91% | -1.80% |
Gross Profit Gross Profit Growth | 381.19 | 399.88 | 367.35 | 460.47 | 316.58 | 250.41 |
Operating Income Operating Income Growth | -419.12 | -410.14 | -40.49 | -71.21 | 3.64 | -42.41 |
Net Income Net Income Growth | -533.78 | -579.4 | -93.45 | -142.26 | -19.16 | -37.6 |
Earnings Per Share EPS Growth | -4.76 | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medicaid Medicaid Growth | 848.3 | 818.31 | 862.4 | 785.05 | 559.36 | 421.07 |
Medicare Medicare Growth | 511.73 | 464.24 | 1,046 | 708.85 | 458.41 | 407.33 |
Commercial and Other Commercial and Other Growth | 528.8 | 593.68 | 646.42 | 469.99 | 334.24 | 79.56 |
Revenue (Total) Revenue (Total) Growth | 1,889 | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 166.01 | 177.99 | 163.5 | 206.59 | 202.69 | 341.97 |
Total Debt Total Debt Growth | 985.43 | 989.7 | 713.67 | 644.8 | 476.12 | 280.47 |
Net Cash (Debt) Net Cash Growth | -819.42 | -811.71 | -550.18 | -438.2 | -273.43 | 61.5 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.23 | -7.11 | -4.80 | -3.94 | -2.92 | 0.71 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 33.29 | 38.84 | 18.77 | 142.58 | -11.55 | 38.75 |
Capital Expenditures CapEx Growth | -31.9 | -34.09 | -24.89 | -28.75 | -38.36 | -24.98 |
Free Cash Flow Free Cash Flow Growth | 1.4 | 4.76 | -6.13 | 113.84 | -49.91 | 13.76 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 20.18% | 21.31% | 14.38% | 23.45% | 23.42% | 27.58% |
Operating Margin | -22.19% | -21.86% | -1.58% | -3.63% | 0.27% | -4.67% |
Pretax Margin | -26.32% | -28.50% | -2.47% | -10.31% | -4.59% | -3.28% |
Profit Margin | -26.38% | -28.49% | -2.41% | -5.76% | -1.38% | -3.34% |
FCF Margin | 0.07% | 0.25% | -0.24% | 5.80% | -3.69% | 1.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 13.52 | 16.88 | 13.66 | 38.40 | 44.32 | 57.19 |
P/FCF Ratio | 59.93 | 93.88 | - | 33.04 | - | 179.36 |
PS Ratio | 0.19 | 0.24 | 0.51 | 1.92 | 2.08 | 2.72 |